Eastwood Bio-Medical Canada 

$1.2
1
+$0.51+72.99% Friday 20:00

Statistics

Day High
0.69
Day Low
0.69
52W High
0.69
52W Low
0.69
Volume
31,000
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

28JunExpected
Q1 2021
Q2 2021
Q1 2022
Q1 2022
Q2 2023
Q4 2023
Q1 2024
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
N/A

Financials

-62.33%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
646,402.83Revenue
-402,910.46Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EWOOF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that manufactures drugs similar to those produced by Eastwood Bio-Medical, targeting similar diseases and conditions.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a large pharmaceutical company that develops and markets medications and supplements that compete directly in the healthcare market with Eastwood Bio-Medical.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline focuses on a broad range of pharmaceutical products, including those in the same therapeutic areas as Eastwood Bio-Medical.
Merck
MRK
Mkt Cap214.76B
Merck is known for its extensive range of health products that could directly compete with Eastwood Bio-Medical's offerings in various medical conditions.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson offers a wide array of medical devices, pharmaceuticals, and health-related products, overlapping with Eastwood Bio-Medical's market.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in similar therapeutic areas, potentially competing with Eastwood Bio-Medical in the field of biopharmaceuticals.
AMGEN
AMGN
Mkt Cap160.66B
Amgen, a biotech firm, develops treatments that could compete with Eastwood Bio-Medical's products, particularly in the specialized biomedicine sector.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb, with its diverse range of pharmaceutical products, competes in the same healthcare space as Eastwood Bio-Medical.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company produces pharmaceutical products that target similar conditions and diseases as those treated by Eastwood Bio-Medical.
Sanofi
SNY
Mkt Cap124.45B
Sanofi operates globally in the pharmaceutical sector, offering products that could directly compete with those of Eastwood Bio-Medical in various health categories.

About

Pharmaceuticals: Other
Health Technology
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. Its licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. The company's products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada. Eastwood Bio-Medical Canada Inc. is a subsidiary of Eastwood Bio-Medical Research Inc.
Show more...
CEO
Country
CA
ISIN
CA27783W1059

Listings

0 Comments

Share your thoughts

FAQ

What is Eastwood Bio-Medical Canada stock price today?
The current price of EWOOF is $1.2 USD — it has increased by +72.99% in the past 24 hours. Watch Eastwood Bio-Medical Canada stock price performance more closely on the chart.
What is Eastwood Bio-Medical Canada stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Eastwood Bio-Medical Canada stocks are traded under the ticker EWOOF.
What were Eastwood Bio-Medical Canada earnings last quarter?
EWOOF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Eastwood Bio-Medical Canada revenue for the last year?
Eastwood Bio-Medical Canada revenue for the last year amounts to 646,402.83 USD.
What is Eastwood Bio-Medical Canada net income for the last year?
EWOOF net income for the last year is -402,910.46 USD.
In which sector is Eastwood Bio-Medical Canada located?
Eastwood Bio-Medical Canada operates in the Other sector.
When did Eastwood Bio-Medical Canada complete a stock split?
Eastwood Bio-Medical Canada has not had any recent stock splits.